Effect of parity on pituitary prolactin response to metoclopramide and domperidone: implications for the enhancement of lactation.

OBJECTIVE: The gastrointestinal motility agents metoclopramide and domperidone are known to increase pituitary prolactin (PRL) secretion and breast milk production. This study compared the effect of single doses of two strengths of metoclopramide and a single dose of domperidone on PRL secretion. METHODS: Ten nonpregnant women had baseline evaluation of serum PRL concentrations. The PRL concentrations were then determined after random oral administration of metoclopramide 10 mg, metoclopramide 5 mg, and domperidone 10 mg. Blood samples were drawn in the first 7 days of the menstrual cycle, at 13 time points over a 6-hour period (0, 15, 30, 45, 60, 75, 90, 120, 150, 180, 240, 300, and 360 minutes), with the zero time point beginning at 0800 hours. Variables such as weight, height, age, gravidity, parity, and oral contraceptive use were recorded. RESULTS: Baseline PRL concentrations showed the natural circadian rhythm. Metoclopramide and domperidone both caused a significant increase in PRL. However, PRL secretion was most influenced by parity. Nulliparous women had the quickest and highest PRL secretion with metoclopramide 10 mg, compared with the PRL response with metoclopramide 5 mg and domperidone 10 mg. Conversely, multiparous women had PRL secretion patterns that were equivalent between the medications. CONCLUSIONS: The PRL response to the medications was most influenced by parity. Therefore, we suggest that the medication therapy of choice for enhancing lactation may not be the same in all women, but may instead be determined by parity.

Molecular characterization of a 40 kDa OmpC-like porin from Serratia marcescens.

An oligonucleotide that encodes the N-terminal portion of a 41 kDa porin of Serratia marcescens was used to probe S. marcescens UOC-51 genomic DNA. An 11 kb EcoRI fragment which hybridized with the oligonucleotide was subcloned into Escherichia coli, examined for expression, and sequenced. The product expressed by the cloned gene was 40 kDa. The nucleotide sequence has an ORF of 1.13 kb. When the deduced amino acid sequence was aligned and compared to other enterobacterial porins the cloned S. marcescens porin most closely resembled E. coli OmpC. Although we did not detect osmoregulation or thermoregulation of any porins in S. marcescens UOC-51, sequences analogous to the E. coli osmoregulator OmpR-binding regions are seen upstream to the cloned gene. We examined the regulation of the S. marcescens porin in E. coli and found that its expression increased in a high salt environment. A micF gene, whose transcriptional product functions to inhibit synthesis of OmpF by hybridizing with the ompF transcript, was also seen upstream of the S. marcescens ompC. An alignment with the E. coli micF gene revealed that the functional region of the S. marcescens micF gene is conserved. Based on the results obtained we have determined that S. marcescens UOC-51 produces a 40 kDa porin similar to the E. coli OmpC porin.

Cloning and analysis of beta-tubulin gene from a protoctist.

We have isolated and characterized by restriction endonuclease mapping, transcription pattern, and DNA sequencing a beta-tubulin gene from the coenocytic freshwater protoctist, Achlya klebsiana. The gene is intronless and has a single open reading frame that encodes a 444-amino acid residue polypeptide of Mr 49,856. The protein shows a high degree of homology to other beta-tubulins, 85% identity to human beta-tubulin and 89% identity to beta-tubulin of the sporozoan (also a protoctist) Plasmodium falciparum. Fungal beta-tubulins are among the least identical to A. klebsiana beta-tubulin. Through Southern blot hybridization analysis, we determined that there is just one form of beta-tubulin gene in A. klebsiana. Transcription of the gene was studied during sporogenesis. Following induction of sporogenesis, the level of the mRNA increased markedly at 2 h and declined in the next 2 h when mitosis, cytokinesis, and spore development occurred. At the same time, beta-tubulin content increased about 6-fold in the cells. Sporulation in A. klebsiana is not inhibited by antimitotic drugs such as benomyl, colcemid, and colchicine. Benomyl resistance in Neurospora crassa and Aspergillus nidulans has been genetically and molecularly linked to single amino acid substitutions at positions 167 and 165, respectively. The change from phenylalanine to tyrosine conferring benomyl resistance to N. crassa is seen in A. klebsiana, but the valine substitution for alanine in A. nidulans is marked by cysteine replacement in A. klebsiana. The amino acid found at position 165 is not conserved in various beta-tubulins, but phenylalanine at position 167 is extremely conserved.